Search Within

Martin Stuart Tallman

Formats
  1. Journal Article (323)
  2. Meeting Abstract (280)
  3. Review (19)
  4. Editorial (10)
  5. Book Section (8)
  6. Research Letter (8)
  7. Guidelines (6)
  8. Correspondence (1)
Groups
  1. Adult Leukemia (655)
  2. Center for Hematologic Malignancies (655)
  3. Department of Medicine (655)
  4. Hematologic Malignancies, Division of (655)
  5. GSK Faculty (164)
  6. Executive Committee, Center for Hematologic Malignancies (156)

More Groups

People
  1. Ross Levine (131)
  2. Eytan Stein (118)
  3. Jae Park (81)
  4. Omar Abdel-Wahab (68)
  5. Sean Devlin (65)
  6. Dan Douer (50)

More People

Years
  1. 2025 (6)
  2. 2024 (10)
  3. 2023 (10)
  4. 2022 (26)
  5. 2021 (45)
  6. 2020 (51)

More Years

Publications
  1. Blood (274)
  2. Journal of Clinical Oncology (41)
  3. Blood Advances (27)
  4. Leukemia Research (27)
  5. Leukemia and Lymphoma (26)
  6. Haematologica (25)

More Publications

Publishers
  1. American Society of Hematology (301)
  2. Elsevier Inc. (44)
  3. American Society of Clinical Oncology (41)
  4. Nature Publishing Group (38)
  5. Taylor & Francis Group (28)
  6. Elsevier Ltd (27)

More Publishers

Results (655)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Hyperactive PTPN11 mutations alters leukemic stem cell frequency through Mcl-1 overexpression
    Meeting Abstract

    Chen, L. L.; Chen, W.; Mysliwski, M.; Serio, J.; Ropa, J.; Abulwerdi, F.; Chan, R. J.; Patel, J. P.; Tallman, M. S.; Paietta, E. M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • BL-8040, a peptidic CXCR4 antagonist, induces leukemia cell death and specific leukemia cell mobilization in relapsed/refractory acute myeloid leukemia patients in an ongoing phase IIA clinical trial
    Meeting Abstract

    Borthakur, G.; Nagler, A.; Ofran, Y.; Rowe, J. M.; Altman, J. K.; Frankfurt, O.; Tallman, M. S.; Avivi, I.; Peled, A.; Pereg, Y.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Telomere length recovery strongly predicts overall survival in acute promyelocytic leukemia
    Meeting Abstract

    Baljevic, M.; Dumitriu, B.; Lee, J. W.; Paietta, E.; Racevskis, J.; Chen, C.; Stein, E. M.; Gallagher, R. E.; Rowe, J. M.; Appelbaum, F. R.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Clinical safety and activity in a phase I trial of AG-120, a first in class, selective, potent inhibitor of the IDH1-mutant protein, in patients with IDH1 mutant positive advanced hematologic malignancies
    Meeting Abstract

    Pollyea, D. A.; de Botton, S.; Fathi, A. T.; Stein, E. M.; Tallman, M. S.; Agresta, S.; Bowden, C.; Fan, B.; Prah, M.; Yang, H.; more...
    European Journal of Cancer (2014)

    Fulltext@MSK | Save
  • Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: An International Consortium on Acute Promyelocytic Leukemia study
    Journal Article

    Lucena-Araujo, A. R.; Kim, H. T.; Jacomo, R. H.; Melo, R. A.; Bittencourt, R.; Pasquini, R.; Pagnano, K.; Fagundes, E. M.; Chauffaille, M. D.; Chiattone, C. S.; more...
    Annals of Hematology (2014)

    Fulltext@MSK | Save
  • DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemia
    Journal Article

    Rampal, R.; Alkalin, A.; Madzo, J.; Vasanthakumar, A.; Pronier, E.; Patel, J.; Li, Y.; Ahn, J.; Abdel-Wahab, O.; Shih, A.; more...
    Cell Reports (2014)

    Fulltext@MSK | Save
  • Quizartinib (Ac220) in patients with flt3-Itd(+) relapsed or refractory acute myeloid leukemia: Final results of a randomized phase 2 study
    Meeting Abstract

    Russell, N.; Tallman, M. S.; Goldberg, S.; Perl, A. E.; Marie, J. P.; Martinelli, G.; Larson, R. A.; Schiller, G.; Trone, D.; Gammon, G.; more...
    Haematologica (2014)

    Fulltext@MSK | Save
  • Treatment with radiation, chemotherapy, or both demonstrates similar outcomes in patients with isolated myeloid sarcoma that may not be different than de novo acute myeloid leukemia
    Meeting Abstract

    Feller, F. M.; Devlin, S. M.; Stein, E. M.; Tallman, M. S.; Rampal, R. K.
    Haematologica (2014)

    Fulltext@MSK | Save
  • Brafv600e mutations in hematopoietic stem cells of hairy cell leukemia patients suggests a stem cell origin
    Meeting Abstract

    Chung, S. S.; Kim, E.; Park, J. H.; Chung, Y. R.; Feldstein, J.; Hu, W.; Rampal, R.; Patel, M.; Kim, M. K.; Huberman, K.; more...
    Haematologica (2014)

    Fulltext@MSK | Save
  • A phase I study of Ag-221, a first in class, potent inhibitor of the Idh2-mutant protein, in patients with Idh2 mutant positive advanced hematologic malignancies
    Meeting Abstract

    Agresta, S.; Stein, E. M.; Tallman, M. S.; Levine, R. L.; Yua, H.; Yen, K.; Fan, B.; Flinn, I. W.; Fathi, A. T.; Stone, R. M.; more...
    Haematologica (2014)

    Fulltext@MSK | Save